Dyadic International, Inc.
Dyadic International, Inc.
Dyadic International, Inc.
DYAI
DYAI
Nasdaq
Health Services
Medical/Nursing Services
1.19
USD
-0.02
-1.65%
Fermé: 07-24 20:00 (UTC+0)
1.19
USD
+0.0559
+4.70%
Après-clôture: 07-25 00:00 (UTC+0)

DYAI Statistiques clés

Haut
1.26
Ouverture
1.21
Volume
105.18K
Bas
1.12
Clôture précédente
1.21
Valeur négociée
125.54K
Plus haut 52 sem.
1.60
Vol. relatif
0.371
Amplitude (%)
11.49%
Plus bas 52 sem.
0.65
Taux de rotation
0.29%
Cap. Marché
43.36M
PER (TTM)
--
PER (Annuel)
--
P/B
-106.35
P/S
11.39
Bénéfice par action (BPA)
-0.214
Dividende (TTM)
0
Rendement du dividende
0.00%
Actions en circulation
36.43M
Devise
USD

DYAI Performance du Prix

7 jour
30 jour
90 jour
180 jour
Depuis le début de l’année
1 An
DYAI Répartition des flux monétaires
DYAI Volume quotidien des ventes à découvert
DYAI Historique du short interest
As of 2026-07-26, the Dyadic International, Inc. (DYAI) stock price today is 1.19. Based on this price, the company has a market capitalization of $43.36M, with a P/E ratio of --. On 2026-07-26, DYAI traded between 1.12 and 1.26. Today’s stock price is 6.25% above the daily low and 5.56% below the daily high, placing DYAI près du milieu de its most recent trading range. Trading volume currently stands at 105.18K, compared with an average daily volume of 283.91K. This suggests that trading activity is nettement inférieur à son niveau habituel than usual. Over the past year, Dyadic International, Inc. shares have traded between 0.65 and 1.60. At today’s price, DYAI is 83.08% above its 52-week low and 25.63% below its 52-week high.
Nom l'entreprise
Dyadic International, Inc.
Secteur
Health Services
Industrie
Medical/Nursing Services
Exchanges
Nasdaq
Nombre d’employés
5
Taille du lot
100
Site officiel
Devise
USD
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.

DYAI FAQ

Recherche
Plus